ADMP - Adamis Pharmaceuticals Corp
Close
0.7751
0.007 0.852%
Share volume: 119,837
Last Updated: Thu 07 Sep 2023 10:00:00 PM CEST
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$0.77
0.01
0.86%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | |
| Report Date | 2022-05-16 | 2022-08-10 | 2022-11-14 | 2023-03-16 | 2023-05-15 | |
| Total revenue | 1.155 M | 39.847 K | 1.506 M | 2.056 M | 1.453 M | |
| Cost of revenue | 1.464 M | 689.178 K | 1.648 M | 2.387 M | 1.788 M | |
| Gross profit | -309.068 K | -649.331 K | -141.902 K | -331.107 K | -335.066 K | |
| -110.09% | 78.15% | -133.33% | -1.20% | |||
| Operating expenses | 7.604 M | 7.527 M | 4.486 M | 4.011 M | 6.093 M | |
| Selling general and admin | 3.383 M | 4.206 M | 2.508 M | 3.151 M | 4.782 M | |
| Research and development | 4.222 M | 3.321 M | 1.978 M | 859.846 K | 1.311 M | |
| Total expenses | 9.068 M | 8.216 M | 6.134 M | 6.398 M | 7.881 M | |
| -9.40% | -25.34% | 4.31% | 23.18% | |||
| Operating income | -7.913 M | -8.176 M | -4.628 M | -4.342 M | -6.428 M | |
| Ebit | -7.913 M | -8.176 M | -4.628 M | -4.342 M | -6.428 M | |
| Pretax income | -10.190 M | -8.335 M | -4.271 M | -3.401 M | -9.015 M | |
| -18.20% | -48.76% | -20.37% | 165.06% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 2.000 K | 0.000 | |
| Net income basic | -10.355 M | -8.397 M | -4.399 M | -3.328 M | -8.943 M | |
| 18.90% | 47.61% | 24.36% | -168.75% | |||
| Net income | -10.355 M | -8.397 M | -4.399 M | -3.328 M | -8.943 M | |
| 18.90% | 47.61% | 24.36% | -168.75% |